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Abstract
Background: This study assessed how family caregivers for patients with Alzheimer’s disease (AD) or dementia in
Japan differed from non-caregivers in characteristics and health outcomes (i.e., comorbidities, health-related quality
of life [HRQoL], productivity, and resource use). Caregivers were hypothesized to experience significantly poorer
outcomes than non-caregivers.
Methods: Data were combined from the 2012 and 2013 National Health and Wellness Survey in Japan (n = 60000).
Caregivers for adult relatives with AD or dementia were compared with non-caregivers on: comorbidities (including
Patient Health Questionnaire (PHQ-9) cutoff scores suggesting presence/absence of major depressive disorder (MDD)),
Work Productivity and Activity Impairment (WPAI), SF-36v2-based HRQoL, and healthcare resource utilization.
Sociodemographic characteristics, health characteristics and behaviors, and Charlson comorbidity index (CCI) scores
were compared across groups. Propensity matching, based on scores generated from a logistic regression predicting
caregiving, was used to match caregivers with non-caregivers with similar likelihood of being caregivers. Bivariate
comparisons across matched groups served to estimate outcomes differences due to caregiving.
Results: Among 55060 respondents, compared with non-caregivers (n = 53758), caregivers (n = 1302) were older (52.6
vs. 47.5 years), more frequently female (53 % vs. 49 %), married/partnered, frequent alcohol drinkers, current smokers,
exercisers, and not employed, and they averaged higher CCI scores (0.37 vs. 0.14), all p < 0.05. Propensity scores
incorporated sex, age, body mass index (BMI), exercise, alcohol, smoking, marital status, CCI, insured status, education,
employment, income, and children in household. A greedy matching algorithm produced 1297 exact matches,
excluding 5 non-matched caregivers. Health utilities scores were significantly lower among caregivers (0.724) vs.
non-caregivers (0.764), as were SF-36v2 Physical and Mental Component Summary scores. Caregivers vs. non-caregivers
had significantly higher absenteeism, presenteeism-related impairment, overall work impairment
(25.8 % vs. 20.4 %, respectively), and activity impairment (25.4 % vs. 21.8 %), more emergency room and traditional
provider visits (7.70 vs. 5.35) in the past six months, and more frequent MDD (14 % vs. 9 %), depression, insomnia,
anxiety, and pain.
Conclusions: Those providing care for patients with AD or dementia in Japan experienced significantly poorer HRQoL
and greater comorbid risk, productivity impairment, and resource use. These findings inform the need for greater
support for caregivers and their patients.
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Background
Alzheimer’s disease (AD) is a progressive neurodegener-
ative disease posing a tremendous burden for patients,
caregivers, and health care systems. Disease symptom-
atology includes, most notably, impaired cognition (e.g.,
memory difficulties), as well as impairments in daily
activities and increasing functional dependence. This
constellation of symptoms results in an increasing de-
gree of care required, often provided by family caregivers
[1]. The cause of AD remains incompletely understood
and currently there is no cure. Currently available treat-
ment is aimed at improving cognitive function and
managing behavioral symptoms [2].
AD is the most common form of dementia, with de-
mentia of the Alzheimer’s type (DAT) projected to in-
crease dramatically over the coming decades due to the
aging global population [3, 4]. Precise global prevalence
estimates have been difficult to establish, but approxi-
mately 4.7 million older adults in the U.S. have been es-
timated to have AD [5]. In Japan in 2010, 2.5 million
adults were estimated to suffer from dementia, ranking
Japan among nine countries with the highest number of
sufferers [6].
Studies have emerged to help better understand the
challenges associated with an aging population in Japan.
A nationwide survey in 2012 reported prevalence of de-
mentia among Japanese aged 65 and over to be 15.8 %,
with AD the most common form, reported among
67.6 % of patients in the same survey [7]. This rate was
considerably higher than previous estimates of dementia
in Japan that ranged from 2.4 %–8.5 %, with AD
developed by 60.8 % of participants with dementia [8, 9].
Evidence suggests that rates of AD are increasing in
Japan [10, 11] and that it represents a major health
concern not only in Japan but across Asia [12]. The
most recent estimates of prevalence suggest an AD rate
of 3.8 % in Japan [10, 13].
Beginning in 2000, Japan has implemented an insur-
ance program and approach to long-term care providing
comprehensive evaluation of the elderly, as well as in-
kind care and financial support for family caregivers
[14]. In 2012, to provide further support for the aging
population, the Japanese government delivered the
Orange Plan for elderly people with dementia. This ini-
tiative includes action plans for early detection and early
diagnosis, as well as funds to continue home care after
the onset of dementia [15].
As noted, care demands are significant for those
diagnosed with AD. The slow, progressive nature of this
disease and functional impairment associated with
symptoms result in many patients being cared for pri-
marily by family members [16]. A growing body of re-
search suggests that the progressive burden of care
associated with AD can have real and significant
deleterious health consequences for these family care-
givers [17].
Empirical studies suggest that family caregivers across
a number of disease conditions have a greater risk of
medical illness, psychological impairment, disruption of
professional and personal roles, and critically, an in-
creased risk of mortality [18–20]. At the same time, evi-
dence suggests that some caregivers find positive effects
associated with caring for a family member diagnosed
with a chronic or terminal disease. Indeed, across dis-
eases such as cancer, heart failure, and AD, studies have
documented benefit-finding and meaning associated
with the caregiver role, and interventions have been de-
veloped that seek to reinforce and promote the positive
effects of caregiving [21–24]. Cheng and colleagues have
reported positive preliminary results of a benefit-finding
intervention for AD caregivers in China, with reductions
in depression reported by the intervention group [22].
Aside from negative and positive effects on mental
and physical health, significant costs have also been rec-
ognized to be associated with informal AD care. In fact,
a recent 2013 European study found that costs associ-
ated with informal caregiving compose the majority of
total societal costs linked with AD (over 50 %) and in-
crease even further with disease severity [25]. A recent
survey revealed a similar situation in Japan, with the
total 2014 societal cost for dementia estimated at $145
billion and the cost of informal care estimated at $62
billion (where $1 = 100 yen) [26]. A number of deleteri-
ous effects have been revealed about caregiver burden
associated with AD [27], including physical [19, 28], psy-
chological [29, 30], social [31], and financial [32] conse-
quences, as well as similar findings beginning to emerge
in developing countries [33].
Although a number of focused studies by Arai and
others have documented substantial burden among
family caregivers of the elderly in Japan, as well as the
challenges associated with providing care, research
quantifying the degree of burden experienced by AD
caregivers across multiple outcomes (encompassing not
just quality of life, but also productivity, comorbidities,
and resource use) in the broader population is lacking
[34–40]. In addition, a qualitative study in 2008 found
that a number of factors were protective against care-
giver burden, including a good prior relationship be-
tween caregiver and patient, and the utilization of
resources by the caregiver [41]. The authors did note
that certain dyads were at greater risk (e.g., husbands
caring for wives), and they recommended services be
put in place to support higher-risk circumstances.
In a recent study, Kamiya and colleagues investigated
factors associated with caregiving burden and found that
behavioral disturbances and lower scores on the Mini-
Mental State Examination (MMSE) were associated with
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increased burden [42]. Finally, Hirono and colleagues ex-
amined the role of caregiver burden in the eventual
institutionalization or death of patients with AD in
Japan. The authors followed 150 individual dyads for at
least one year and found that initial caregiver burden
was a significant predictor of both outcomes: death and
transition of care to an institution [43]. Critically, the au-
thors found that the early use of resources to aid in care
(namely, daycare and home care services) were once
again protective factors that reduced burden. The au-
thors concluded that caregiver education was needed to
increase understanding of the meaning and necessity of
supportive care services and their ability to reduce care-
giver burden.
Interventions targeting caregivers have been the topic
of emerging research, although little has been published
in Japan. A 1999 study by Hosaka and Sugiyama investi-
gated the effects of a pilot program for AD caregivers,
reporting that a 5-week educational and supportive
group program resulted in significant improvements in
mood and functioning among caregivers [44].
Despite the lack of nationwide research on supportive
care programs in Japan, in recognition of the high degree
of burden experienced by AD caregivers, Hashimoto et al.
reported the beneficial effect of donepezil hydrochloride
(approved for treatment of DAT) on caregiver burden, find-
ing that caregivers of symptomatic patients reported a sig-
nificant decrease in burden over the course of the 12-week
trial [45]. Hishikawa et al. reported that garantamine
treatment of patients with AD reduced behavioral and
psychological symptoms of dementia and corresponding
caregiver burden in a six-month retrospective evaluation
study [46], while Kuroda et al. reported that rivastigmine
was also associated with reduced caregiver burden [47].
This, along with supportive therapies, represents an import-
ant but under-researched domain of investigation.
Large-scale population-based studies, particularly those
that include both urban and rural participants, and a
broad range of psychosocial and economic outcomes, pro-
vide critical information that can enhance our under-
standing of caregiver burden, as well as helping guide the
development and implementation of appropriate support
services for this important and under-represented care-
giver population. The current study therefore aims to add
to the general literature this breadth of information, as
well as help address a gap in the literature concerning the
effects of AD caregiving on Japanese caregivers’ work
productivity and resource use, an issue of great relevance
in the context of a rapidly aging population [48]. The
study will assess how family caregivers for patients with
AD or dementia in Japan differed from non-caregivers in
terms of their characteristics and health outcomes (i.e.,
comorbidities, health-related quality of life [HRQoL],
productivity, and resource use).
Methods
Sample
This study analyzed existing data from caregivers identi-
fied in the 2012 and 2013 Japan National Health and
Wellness Surveys (NHWS; total n = 60000). NHWS is a
self-administered, self-reported, Internet-based question-
naire of a sample of adults (aged 18 or older), collecting
sociodemographic and general health history informa-
tion, as well as information on comorbid conditions,
medication usage, and health outcomes, etc. Stratified
samples (by sex and age) were implemented to ensure
demographic compositions representative of correspond-
ing adult populations. Respondents were originally se-
lected from opt-in consumer panels; see further details
about the panel recruitment in a very similar study and
analysis using Brazil data [33], as well as details about
the Japan panel in particular and how well it aligned
with census data regarding gender, age, income, and re-
gion [49]. NHWS respondents needed to read and write
in Japanese and to provide their informed consent in
order to participate in the Japan NHWS. The NHWS
protocol and questionnaire were reviewed and approved
by Essex Institutional Review Board (Lebanon, New
Jersey, USA). Other published studies have also used
NHWS Japan data, with additional details provided on
incentives and translation procedures [49–51].
Caregivers were defined as those who reported cur-
rently caring for an adult relative, with “Alzheimer’s dis-
ease or dementia” selected among fifteen prompted
conditions (n = 1302). Non-caregivers were defined as
those not currently caring for an adult relative with any
of the other prompted conditions or any unprompted
condition (n = 53758). Excluded from analyses were
caregivers for adult relatives with any other condition, as
well as 2012 data from respondents who participated in
both years of NHWS (i.e., only 2013 data were retained
to avoid double-counting respondents).
Measures
Baseline comorbidities
The Charlson comorbidity index (CCI; [52]) weights the
presence of several mortality-predicting conditions and
sums the result, with higher total index scores indicating
greater comorbid burden on the patient. In the re-
contact study, the Quan et al. [53] scoring of CCI was
used, providing an updated scoring algorithm based on
fewer conditions (congestive heart failure, dementia,
chronic pulmonary disease, rheumatologic disease, mild
liver disease, diabetes with end organ damage, hemiplegia,
moderate/severe renal disease, metastatic tumor, acquired
immune deficiency syndrome/human immunodeficiency
virus, and lymphoma, leukemia, or any tumor) and reflect-
ing weighting from a more recent replication. CCI scores
were assessed as covariates, not as outcomes of interest,
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given their likely role as pre-occurring conditions to care-
giving. The greater the total index score (ranging from 0
to 24 theoretically), the greater the comorbid burden on
the caregiver. Paraplegia and moderate/severe liver disease
were not assessed in NHWS and were therefore excluded
from the scoring (with a corresponding maximum score
of 22).
Sociodemographics, health characteristics and behaviors
In NHWS, additional variables were compared across
caregivers vs. non-caregivers, including: sex, age, marital
status, employment, income, education, children in house-
hold, smoking, drinking alcohol, exercise, body mass index
(BMI), and health insurance.
Comorbidities
Select comorbidities were examined to assess the comor-
bid burden associated with caregiving. Self-reported
diagnosis “by a physician” with depression, anxiety, in-
somnia, hypertension, pain, and diabetes (Type 1/2)
were assessed as outcomes of interest, given their poten-
tial role as consequences of caregiving, or as conditions
exacerbated by caregiving.
Depression
The Patient Health Questionnaire (PHQ-9; [54, 55])
measures frequency of depression symptoms, with items
scored on a 4-point scale (not at all = 0 to nearly every
day = 3). A cut-off of ≥ 10 vs. < 10 [56], suggestive of
major depressive disorder (MDD), was used in addition
to the “diagnosed depression” measure.
Work productivity
Productivity impairments were assessed using the four
metrics of the Work Productivity and Activity Impair-
ment (WPAI) questionnaire [57, 58], with respect to
one’s health in the past seven days. Absenteeism was
quantified as percentage of work time missed, based on
reported hours missed divided by hours worked plus
missed. Presenteeism was based on reported percentage
impairment experienced while at work. Overall work
productivity loss was quantified as a percentage combin-
ing absenteeism plus presenteeism multiplied by per-
centage time worked. Activity impairment was based on
reported percentage impairment in daily activities. Only
respondents who reported being full-time, part-time, or
self-employed provided data for absenteeism, presentee-
ism, and overall work impairment. Among all respon-
dents, WPAI assessed the effect of their health on daily
activities. Higher percentage values indicate greater
impairment.
HRQoL
Short Form (SF)-36v2-derived scores [59], including
Physical (PCS) and Mental (MCS) Component Summary
scores, normed to a mean of 50 and standard deviation
of 10 based on the US population, along with health
state utilities derived via the SF-6D algorithm [60], were
used to assess the overall burden associated with care-
giving. Higher scores indicate better health status, and
differences exceeding 3 points (PCS and MCS) or 0.041
points (SF-6D health utilities) are considered minimally
important differences (MIDs; [59, 61]).
Healthcare resource utilization
Self-reported resource use, independent of a specific
cause, was defined by the number of traditional health-
care provider visits, emergency room (ER) visits, and
hospitalizations for one’s medical condition in the past 6
months, as well as frequency of any (1+ vs. 0) visits.
Analysis
Descriptive analyses
Descriptive results were examined for all study variables
of interest, including sample sizes and proportions for
categorical variables and means, standard deviations
(SDs), ranges, and percentiles for continuous variables.
Demographics and health characteristics were analyzed
for the total sample, to identify the characteristics of
caregivers in Japan, as well as to identify the characteris-
tics of non-caregivers.
Bivariate analyses
Significant differences were assessed among caregivers
for patients with AD or dementia, compared with non-
caregivers, using two - sample binomial proportion and
Chi-square tests of independence (frequencies) or inde-
pendent sample t tests (means). Caregiver demographics
and health characteristics were compared first, in order
to understand baseline differences and inform variables
included as covariates in multivariable analysis.
Multivariable analyses
Given initial evidence of baseline discrepancies between
caregivers and non-caregivers, propensity matching was
used to control for confounding. A binary logistic re-
gression model, predicting caregiver vs. non-caregiver
status as a function of all potential baseline variables
(sex, age, BMI, exercise, alcohol, smoking, marital status,
CCI, insured status, education, employment, income,
and children in household), was used to generate pro-
pensity scores. These scores represent the propensity of
inclusion in one group vs. the other, based on an indi-
vidual’s values on all the covariates. Caregivers were each
then matched with non-caregivers who had similar prob-
abilities of having been caregivers, according to their
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scores. Bivariate comparisons on this select subset of
caregivers and non-caregivers were used to provide an
estimate of how health outcomes differ between these
populations. The one-to-one matching was conducted
using a “greedy matching” algorithm, excluding respon-
dents who did not have an exact match within the speci-
fied level of precision.
Results
Among 60000 total 2012 + 2013 NHWS respondents,
1302 unique (i.e., non-duplicated) caregivers for an
adult relative with AD or dementia were compared
against 53758 non-caregivers (i.e., those not currently
caring for an adult relative with any condition), total
n = 55060. Caregivers in Japan were on average
52.6 years old, and 53.0 % were female, 68.2 % mar-
ried or living with a partner, 98.5 % insured, and
20.7 % living with one or more children in the house-
hold (see Table 1).
With respect to baseline characteristics, caregivers,
compared with non-caregivers, were on average older,
more frequently female, married/partnered, frequent
alcohol drinkers, current smokers, and exercisers, and
they had higher average CCI scores and were less
likely to be employed. Caregivers vs. non-caregivers
were also more likely to have health insurance,




Caregivers vs. non-caregivers experienced greater de-
pression, whether demonstrated in higher PHQ-9 scores
indicating greater severity, greater frequency of MDD
according to the PHQ-9, or greater likelihood of self-
reported diagnosis with depression (Table 2). Caregivers
vs. non-caregivers also reported more frequent insomnia,
anxiety, hypertension, pain, and diabetes.
HRQoL
Caregivers vs. non-caregivers experienced significantly
lower health utilities, reaching the MID for meaningfully
poorer HRQoL. Caregivers also had significantly lower
PCS and MCS scores, indicating poorer physical and
mental health status, respectively (Table 2).
Work productivity
Caregivers vs. non-caregivers reported significantly higher
activity impairment, as well as (among employed respon-
dents only) greater absenteeism, presenteeism-related
impairment, and overall work impairment (Table 2).
Resource use
Caregivers vs. non-caregivers reported significantly more
visits to the ER, hospital, and healthcare providers in the
past 6 months (Table 2).
Matched comparisons
Comorbidities
With one-to-one propensity matching, where 1297 out
of 1302 caregivers were successfully matched against
1297 non-caregivers, many comorbidities remained
significantly different across the two groups (Table 3).
Namely, caregivers vs. non-caregivers experienced greater
depression, based on higher PHQ-9 scores (4.4 vs. 3.1),
more frequent PHQ-9 based MDD (14.2 % vs. 8.6 %), and
more frequent self-reported diagnosed depression (6.2 %
vs. 3.2 %), all p < 0.05. Caregivers vs. non-caregivers also
reported more frequent insomnia (9.8 % vs. 5.7 %), anxiety
(1.9 % vs. 0.4 %), and pain (15.5 % vs. 10.6 %), all p < 0.05.
Hypertension and diabetes no longer differed significantly.
HRQoL
Matched caregivers vs. non-caregivers experienced sig-
nificantly lower health utilities (0.724 vs. 0.764), p < 0.05,
nearly reaching the MID for meaningfully poorer
HRQoL (Table 3). Caregivers also had significantly
lower PCS (51.60 vs. 52.73) and MCS (46.00 vs.
48.60), both p < 0.05.
Work productivity
Matched caregivers vs. non-caregivers reported significantly
higher activity impairment (25.4 % vs. 21.8 %), as well as
greater absenteeism (5.4 % vs. 3.1 %), presenteeism-related
impairment (22.7 % vs. 18.4 %), and overall work impair-
ment (25.8 % vs. 20.4 %), all p < 0.05 (Table 3).
Resource use
Matched caregivers vs. non-caregivers reported signifi-
cantly more visits to the ER (0.27 vs. 0.08) and health-
care providers (7.70 vs. 5.35) in the past 6 months, both
p < 0.05, but not significantly more hospital visits (0.79
vs. 0.81). Matched caregivers vs. non-caregivers also re-
ported more frequently any visits to the ER (7.2 % vs.
4.0 %), hospital (8.1 % vs. 5.1 %), and healthcare pro-
viders (74.9 % vs. 61.9 %), all p < 0.05 (Table 3).
Discussion
The diagnosis of a terminal or chronic illness can often
result in family members being required to provide in-
formal care to patients. Whereas this form of caregiving
can have positive effects through benefit-finding and
meaning assigned to caring [21–24] across a variety of
diseases, it can also be associated with significant burden
in physical and psychosocial domains. In the current
study, significant burden was identified among individuals
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Table 1 Sociodemographics and health characteristics as a function of caregiver status
Non-caregivers (n = 53758) Caregivers (n = 1302) Total (n = 55060)
Mean/% SD/n Mean/% SD/n Mean/% SD/n
Age of the respondent: mean 47.53 15.66 52.63* 13.89 47.65 15.64
Age: category 18–29 17.1 % 9191 11.2 % 146* 17.0 % 9337
30–39 18.7 % 10045 8.8 % 114* 18.5 % 10159
40–49 17.9 % 9635 10.8 % 140* 17.8 % 9775
50–64 25.6 % 13765 46.2 % 602* 26.1 % 14367
≥65 20.7 % 11122 23.0 % 300* 20.7 % 11422
Gender Female 49.2 % 26425 53.0 % 690* 49.2 % 27115
Male 50.8 % 27333 47.0 % 612* 50.8 % 27945
BMI category Underweight 11.0 % 5910 9.8 % 128 11.0 % 6038
Normal weight 67.9 % 36486 68.7 % 894 67.9 % 37380
Overweight 14.7 % 7909 16.4 % 214 14.8 % 8123
Obese 2.7 % 1433 3.1 % 41 2.7 % 1474
Unknown 3.8 % 2020 1.9 % 25* 3.7 % 2045
Exercise frequency (20+ minutes)
in past month
0–11 times 83.6 % 44933 80.6 % 1050* 83.5 % 45983
≥12 times 16.4 % 8825 19.4 % 252* 16.5 % 9077
Alcohol use per week ≤ once 61.6 % 33131 54.6 % 711* 61.5 % 33842
≥2–3 times 38.4 % 20627 45.4 % 591* 38.5 % 21218
Smoke cigarettes No 79.7 % 42842 74.9 % 975* 79.6 % 43817
Yes 20.3 % 10916 25.1 % 327* 20.4 % 11243
Marital status Single 30.2 % 16252 22.9 % 298* 30.1 % 16550
Married/living with partner 62.4 % 33519 68.2 % 888* 62.5 % 34407
Divorced/separated/widowed > 1 year 7.0 % 3777 8.2 % 107 7.1 % 3884
Divorced/separated/widowed≤ 1 year 0.4 % 210 0.7 % 9 0.4 % 219
CCI: mean score 0.136 0.47 0.369* 1.67 0.14 0.53
CCI: category 0 89.3 % 48022 80.8 % 1052* 89.1 % 49074
1 8.5 % 4556 13.5 % 176* 8.6 % 4732
2 1.7 % 906 3.1 % 40* 1.7 % 946
>3 0.5 % 274 2.6 % 34* 0.6 % 308
Health insurance None of the above 3.2 % 1731 1.5 % 19* 3.2 % 1750
National/Social/Late Stage Elderly 96.8 % 52027 98.5 % 1283* 96.8 % 53310
Types of current medical insurance National Health Insurance 44.9 % 24142 50.1 % 652* 45.0 % 24794
Social Insurance 48.7 % 26207 45.9 % 598* 48.7 % 26805
Late Stage Elderly Insurance 1.5 % 780 1.1 % 14 1.4 % 794
Other 1.7 % 898 1.5 % 19 1.7 % 917
None of the above 3.2 % 1731 1.5 % 19* 3.2 % 1750
Education: college or above High school or lower 36.6 % 19651 33.3 % 433* 36.5 % 20084
College or above 63.4 % 34107 66.7 % 869* 63.5 % 34976
Highest level of education completed
or highest degree received
Elementary School 0.2 % 121 0.3 % 4 0.2 % 125
Junior High School 2.5 % 1346 2.0 % 26 2.5 % 1372
High School 33.8 % 18184 31.0 % 403* 33.8 % 18587
2 Year College 15.6 % 8385 15.9 % 207 15.6 % 8592
4 Year College 42.7 % 22966 45.2 % 588 42.8 % 23554
Graduate School 5.1 % 2756 5.7 % 74 5.1 % 2830
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providing informal care for those diagnosed with AD or
dementia. These findings are aligned with previous studies
both in Japan and globally, suggesting that the burden ex-
perienced by caregivers extends across geographies, in
spite of any influence of individual healthcare systems or
cultural differences. Moreover, given little research in
Japan investigating this form of burden or exploring its ef-
fects on health and economic outcomes, the current study
identified potential impact of caregiving not only on qual-
ity of life, but also on comorbidities, productivity, and
use of healthcare resources.
The caregivers recruited in the current study were on
average 52.6 years old, somewhat younger than those in-
volved in other studies of AD (e.g. 63.8 years [45]); how-
ever, as in the current study, the majority of caregivers
in previous studies were female [45]. The age difference
may be representative of the Internet-based format of
this study, which may recruit younger individuals more
comfortable with the online format.
The current study found that across a majority of
health outcome measures, caregivers experienced signifi-
cantly greater burden than did non-caregivers, even after
matching them against non-caregivers with very similar
baseline characteristics. Caregivers experienced greater
frequency of comorbidities, including depression, insom-
nia, anxiety, and pain compared with non-caregivers.
Compared with non-caregivers, caregivers reported
significantly lower health utilities, nearly reaching the
MID for meaningfully poorer HRQoL, and they had
significantly poorer physical and mental health status.
Similar associations have been reported in the global
literature, including among caregivers in the UK and
Europe [62–64], thus reinforcing the critical importance
of providing support to this vulnerable group.
Further, significant economic consequences were found
among study caregivers compared with matched controls.
These individuals reported significantly higher work prod-
uctivity and activity impairment across all metrics. Finally,
caregivers reported significantly greater resource use: i.e.,
more visits to the ER and healthcare providers in the
previous six months and more frequent reports of any
visit to the ER, hospital, or healthcare providers, further
reinforcing the multifaceted economic impact of caregiver
burden, as noted in previous studies outside of Japan [25].
With respect to baseline characteristics, caregivers had
relatively poorer health and greater comorbid risk than
(all, i.e., unmatched) non-caregivers, but they also had
more financial resources at their disposal, lack of employ-
ment notwithstanding.
The current results align with previous global care-
giver studies, including in particular a recent, similar
analysis of burden among 209 caregivers of AD patients
in NHWS Brazil [33]. For example, relative to their cor-
responding non-caregiver peers, the Japanese caregivers
in the current study experienced health utilities impair-
ments (−0.040 points) comparable to those of the Brazil
caregivers (−0.024), as well as comparable impairments
on PCS (−1.13 in Japan vs. -0.94 in Brazil) and MCS
(−2.60 vs. -1.70, respectively), overall work impairment
(26.5 % greater impairment in Japan vs. 35.9 % greater in
Brazil), absenteeism (75.3 % vs. 59.6 % greater, respect-
ively), presenteeism-related impairment (23.3 % vs.
32.7 % greater), activity impairment (16.6 % vs. 16.7 %
greater), provider visits (43.9 % vs. 28.7 % greater), de-
pression (odds ratio [OR] of 2.0 in Japan vs. 2.0 in
Brazil), MDD (OR = 1.8 vs. 1.5, respectively), anxiety
(OR = 4.8 vs. 1.7), insomnia (OR = 1.8 vs. 1.6), and pain
(OR = 1.5 vs. 1.7).
Table 1 Sociodemographics and health characteristics as a function of caregiver status (Continued)
Employment status Not employed, disabled, retired, student,
or homemaker
40.5 % 21790 43.8 % 570* 40.6 % 22360
Full-time, part-time, or self-employed 59.5 % 31968 56.2 % 732* 59.4 % 32700
Income < ¥3,000,000 18.6 % 10012 18.0 % 234 18.6 % 10246
¥3,000,000 to < ¥5,000,000 26.1 % 14014 23.3 % 303* 26.0 % 14317
¥5,000,000 to < ¥8,000,000 25.2 % 13564 25.5 % 332 25.2 % 13896
≥ ¥8,000,000 20.3 % 10937 27.3 % 356* 20.5 % 11293
Declined to answer 9.7 % 5231 5.9 % 77* 9.6 % 5308
Children (<18) in household 0 75.1 % 40376 79.3 % 1032* 75.2 % 41408
1 13.1 % 7038 12.3 % 160 13.1 % 7198
2 9.5 % 5125 6.6 % 86* 9.5 % 5211
≥3 2.3 % 1219 1.8 % 24 2.3 % 1243
Caregivers were defined as those currently caring for an adult relative with Alzheimer’s disease or dementia, whereas non-caregivers were those not currently
caring for an adult relative with any listed condition
BMI body mass index, CCI Charlson comorbidity index, SD standard deviation
*p < 0.05 for the two-tailed significance of differences across caregivers and non-caregivers within a given row
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The impairments found in the current study were also
comparable to those reported by caregivers for adult rela-
tives diagnosed with cancer in yet another NHWS-based
study in the EU, where health utilities were 0.043 points
lower for caregivers vs. non-caregivers (vs. 0.040 points
lower for Japanese caregivers in the current study), PCS
and MCS were 1.29 and 3.26 points lower, respectively (vs.
1.13 and 2.60 in the current study), overall work impair-
ment, absenteeism, presenteeism-related impairment, and
activity impairment were 46, 69, 45, and 32 % greater, re-
spectively (vs. 26 %, 75 %, 23 %, and 17 % greater), provider
visits were 33.2 % greater (vs. 43.9 %), and depression, anx-
iety, and insomnia had ORs = 1.5, 2.0, and 2.0, respectively
(vs. 2.0, 4.8, and 1.8) [65].
In yet another NHWS-based study in the US, the burden
of caregiving for patients with AD was compared with that
for patients with multiple sclerosis (MS), finding that
impairments did not differ significantly across the two con-
ditions in terms of work productivity measures, HRQoL, or
provider visits, although activity impairment, ER visits, and
hospitalizations were significantly greater for caregivers of
patients with MS [66].
It is important to note that the comparisons of care-
giver burden referenced above are with respect to gen-
eral health outcomes domains: mental health-related
comorbidities, overall mental and physical status, prod-
uctivity impairments, and resource use. There may be
other, more disease-specific variations in burden that
were not captured in the current or comparable studies.
For example, the specific needs and psychological expe-
riences of caring for individuals with severe dementia or
AD may differ from those of caregiving in other condi-
tions, even as general health outcome impairments are
similar in degree. Generally, with variations in terms of
Table 2 Health outcomes as a function of caregiver status
Non-caregivers (n = 53758) Caregivers (n = 1302) Total (n = 55060)
Mean/% SD/n Mean/% SD/n Mean/% SD/n
PHQ-9 3.18 4.75 4.40* 5.48 3.21 4.77
PHQ-9: category PHQ-9: < 10 91.1 % 48957 85.8 % 1117* 90.9 % 50074
PHQ-9: ≥ 10 (MDD) 8.9 % 4801 14.2 % 185* 9.1 % 4986
Diagnosed comorbidities
Depression 3.3 % 1778 6.2 % 81* 3.4 % 1859
Insomnia 4.4 % 2361 9.8 % 128* 4.5 % 2489
Anxiety 0.8 % 448 2.0 % 26* 0.9 % 474
Hypertension 11.7 % 6290 17.5 % 228* 11.8 % 6518
Pain 7.9 % 4269 15.5 % 202* 8.1 % 4471
Diabetes (Type 1/2) 3.7 % 1981 6.1 % 79* 3.7 % 2060
SF-6D 0.765 0.121 0.724* 0.124 0.764 0.121
SF-36v2: Physical Component Summary 53.57 6.09 51.58* 6.62 53.52 6.11
SF-36v2: Mental Component Summary 48.01 9.61 46.00* 10.65 47.96 9.64
WPAI: % absenteeism: work missed due to healtha 2.87 12.38 5.38* 15.79 2.93 12.47
WPAI: % presenteeism-related impairment: impairment while
working due to healtha
18.64 23.21 22.75* 25.42 18.73 23.27
WPAI: % overall work impairment due to healtha 20.26 25.23 25.69* 28.16 20.38 25.31
WPAI: % activity impairment due to health 20.71 24.44 25.43* 25.82 20.83 24.49
Emergency room visits, past 6 months 0.08 0.89 0.29* 1.78 0.09 0.92
Hospitalizations, past 6 months 0.46 4.09 0.83* 5.23 0.47 4.12
Traditional healthcare provider visits, past 6 months 4.38 7.70 7.74* 18.53 4.46 8.14
Emergency room visits (1+), past 6 months 3.2 % 1722 7.3 % 95* 3.3 % 1817
Hospitalizations (1+), past 6 months 4.0 % 2152 8.2 % 107* 4.1 % 2259
Traditional healthcare provider visits (1+), past 6 months 56.5 % 30388 74.9 % 975* 57.0 % 31363
Caregivers were defined as those currently caring for an adult relative with Alzheimer’s disease or dementia, whereas non-caregivers were those not currently car-
ing for an adult relative with any listed condition
MDD major depressive disorder, PHQ patient health questionnaire, SD standard deviation, SF short form, WPAI work productivity and activity impairment
*p < 0.05 for the two-tailed significance of differences across caregivers and non-caregivers within a given row
aAbsenteeism and overall work impairment results were available only for employed respondents, excluding those who both worked and missed 0 h, as well as
outliers who reported > 112 potential work hours in the past week (n = 30737: 693 caregivers and 30044 non-caregivers). Presenteeism-related impairment results
were available only for employed respondents who worked >0 h in the past week (n = 31460: 712 caregivers and 30748 non-caregivers)
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magnitude and significance of differences across health
outcomes, the current study finds that caregivers for pa-
tients with AD in Japan experienced impairments com-
parable to those experienced by caregivers for patients
with AD in other geographies (e.g., Brazil and US), as
well as impairments experienced by caregivers for pa-
tients with other conditions (cancer, MS, and schizo-
phrenia) across geographies [65–67].
Strengths and limitations
The online survey format provides certain sampling ad-
vantages, including a broad representation of the overall
population (including alignment with census data for
Japan) and wide variance in caregiver and non-caregiver
characteristics, but it may under-represent caregivers
without access to or comfort with online technology
(i.e., those who are not “digitally literate”). This online
format may also bias recruitment toward younger,
wealthier segments of society. Despite this, the fact that
significant impairment and burden was established even
among this group of caregivers suggests that under-
represented groups (older, resource poor) may experi-
ence even greater burden than what was found in the
current study.
While this study provides important insight into the
potential health and economic effects of caregiving in
the context of AD, the cross-sectional study design pre-
cludes any definitive conclusions from being drawn
about causal relationships. Moreover, the self-report na-
ture of the NHWS provides the potential for recall and
other reporting biases (e.g., imprecise or inaccurate esti-
mates of time, past productivity, and past resource use).
The NHWS did not collect information regarding the
relationship status between patients and their caregivers,
Table 3 Health outcomes as a function of caregiver status across propensity-matched groups
Non-caregivers (n = 1297) Caregivers (n = 1297) Total (n = 2594)
Mean/% SD/n Mean/% SD/n Mean/% SD/n
PHQ-9 3.09 4.68 4.39* 5.47 3.74 5.13
PHQ-9: category PHQ-9: < 10 91.4 % 1185 85.8 % 1113* 90.9 % 2298
PHQ-9: ≥ 10 (MDD) 8.6 % 112 14.2 % 184* 9.1 % 296
Diagnosed comorbidities
Depression 3.2 % 42 6.2 % 80* 3.4 % 122
Insomnia 5.7 % 74 9.8 % 127* 4.5 % 201
Anxiety 0.4 % 5 1.9 % 25* 0.9 % 30
Hypertension 17.3 % 225 17.4 % 226 11.8 % 451
Pain 10.6 % 138 15.5 % 201* 8.1 % 339
Diabetes (Type 1/2) 7.9 % 103 6.1 % 79 3.7 % 182
SF-6D 0.764 0.123 0.724* 0.124 0.744 0.125
SF-36v2: Physical Component Summary 52.73 6.71 51.60* 6.61 52.17 6.69
SF-36v2: Mental Component Summary 48.60 9.52 46.00* 10.65 47.30 10.18
WPAI: % absenteeism: work missed due to healtha 3.08 12.30 5.40* 15.81 4.25 14.23
WPAI: % presenteeism-related impairment: impairment
while working due to healtha
18.44 23.83 22.74* 25.39 20.62 24.72
WPAI: % overall work impairmenta 20.36 25.66 25.75* 28.18 23.09 27.09
WPAI: % activity impairment 21.79 25.37 25.41* 25.82 23.60 25.66
Emergency room visits, past 6 months 0.08 0.56 0.27* 1.68 0.18 1.26
Hospitalizations, past 6 months 0.81 6.72 0.79 5.15 0.80 5.99
Traditional healthcare provider visits, past 6 months 5.35 8.59 7.70* 18.50 6.53 14.47
Emergency room visits (1+), past 6 months 4.0 % 52 7.2 % 94* 3.3 % 146
Hospitalizations (1+), past 6 months 5.1 % 66 8.1 % 105* 4.1 % 171
Traditional healthcare provider visits (1+), past 6 months 61.9 % 803 74.9 % 971* 57.0 % 1774
Caregivers were defined as those currently caring for an adult relative with Alzheimer’s disease or dementia, whereas non-caregivers were those not currently
caring for an adult relative with any listed condition
MDD major depressive disorder, PHQ patient health questionnaire, SD standard deviation, SF short form, WPAI work productivity and activity impairment
*p < 0.05 for the two-tailed significance of differences across caregivers and non-caregivers within a given row
aAbsenteeism and overall work impairment results were available only for employed respondents, excluding those who both worked and missed 0 h, as well as
outliers who reported > 112 potential work hours in the past week (n = 1364: 691 caregivers and 673 non-caregivers). Presenteeism-related impairment results
were available only for employed respondents who worked > 0 h in the past week (n = 1397: 709 caregivers and 688 non-caregivers)
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nor did it collect information on the level or type of care
being provided. Many caregivers may have been the off-
spring of patients, as suggested by the relatively young
age of caregivers in the current study. To the extent that
this was the case, AD may have a meaningful impact on
the work productivity of younger caregivers in the work-
ing population. It should be noted that the caregiving
relationship can be complex and shift over time, influ-
enced by both patient and caregiver characteristics, ex-
ternal pressures, and the availability of financial and
other resources. Future research should thus clarify
caregiver-patient relationships and surrounding issues,
further elucidating the role that family members assume
in caring for those with AD, which can inform the
provision of more effective supportive services.
Moreover, the NHWS did not provide data on the pre-
cise proportion of caregivers who cared for patients with
DAT vs. other forms of dementia. While research sug-
gests that AD composes a majority of dementia among
patients, it is unclear how this translates into caregiving
(e.g., whether caregiving is more prevalent among AD
patients). Also, the NHWS did not provide data on pa-
tients’ disease progression and severity, and patients with
more severe disease are expected to have correspond-
ingly older caregivers and poorer patient outcomes [25,
45]. Therefore, future research should assess the specific
contributions of different types of dementia or disease
severity to types and degree of caregiver burden.
Finally, the NHWS did not provide detailed data on
non-caregivers’ family relationships, meaning that the
incremental burden observed in caregivers vs. non-
caregivers may in some part have been caused by con-
cerns relating merely to having an older relative with or
without dementia, regardless of caregiving status. At the
same time, the propensity matching employed in the
study (especially controlling for variables such as age,
employment and marital status, and children in the
household) should have limited considerably the hetero-
geneity among non-caregivers and provided a relatively
focused comparison against a pool of matched non-
caregivers similar to the caregivers.
Additional studies are needed to better understand
those who are non-caregivers, particularly for the subset
of persons who have a relative with dementia but have not
taken on caregiver responsibilities. This research may help
elucidate how and why people become caregivers and the
impact of not being able to fulfill the role of caregiver.
Implications
The current study reinforces understanding of the sig-
nificant health-related burden that AD caregivers can
experience, extending this research and quantifying the
impact family caregiving can have not only on quality of
life but also on comorbidities, work productivity, and
healthcare resource use. Supportive care programs for
caregivers often rely upon traditional counseling
modalities, requiring time away from caregiving re-
sponsibilities and potentially hampered by stigma
surrounding mental health. The potential for family
caregiving to impair work productivity could there-
fore suggest innovative worksite-based interventions
and provide a preliminary basis for gaining employer
support. Such interventions could provide both instru-
mental (e.g., time to run errands) and emotional support
in a less stigma-prone environment, while reducing time
spent away from caregiving responsibilities and mitigating
the negative impact of caregiving on work productivity. At
the same time, interventions focused on screening and
treatment of depressive symptoms may offer another mo-
dality via which to identify and reach out to caregivers,
perhaps focusing on strengthening the positive aspects of
caregiving to better address the unique needs of this
population.
Conclusions
Those providing care for patients with dementia (including
dementia due to AD) in Japan experience a broad range of
care-related burden (physical, psychological, social, and fi-
nancial), with relatively greater comorbid risk, poorer
HRQoL, greater productivity impairment, and higher rates
of healthcare resource use. Given aging world populations
and corresponding projected increases in AD/dementia
diagnoses over time, direct treatment and policies to help
caregivers and their patients are needed. Special consider-
ation may need to be given to interventions related to work
environments and screening/treatment of depression, given
productivity impairments and comorbidities identified
among the range of health outcomes assessed in the
current study. With Japan’s demographic changes leading
to a relatively small workforce supporting the care and fi-
nancial needs of a growing elderly population, policymakers
need to consider the impact of caregiving on many aspects
of society. The current study helps to better characterize
caregivers in order to help identify where support is most
needed. Further research in Japan can help elucidate the
broader impact of AD on caregivers and society in general,
including assessments of how the caregiver experience is
influenced by AD severity and current forms of assistance
(e.g., private care and insurance programs), as well as as-
sessments of interventions to assist caregivers.
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